Gitte Knudsen

Professor of Neurology at Copenhagen University Hospital

Data updated

Papers

28 publications

Trials

0 clinical trials

Research Footprint

Gitte Knudsen appears in 28 tracked papers (2011–2026), most studied alongside Psilocybin, LSD and MDMA, across Neuroimaging & Brain Measures, Healthy Volunteers and Depressive Disorders.

Most-cited paper: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (491 citations).

Frequent co-authors: Patrick Fisher, Dea Stenbæk and Mads Madsen.

Background & Research

Gitte Moos Knudsen is a clinical neurologist and professor at the University of Copenhagen. As Director of NeuroPharm, she utilizes PET and fMRI to evaluate brain receptor occupancy and the functional impact of drugs. Her research in the psychedelic field explores how psilocybin modulates the serotonin system and brain connectivity to inform treatments for depression and neurological disorders.

Key Impact

Translational neurobiologist leading multi-modal imaging research on the serotonin system and psilocybin.

28

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

36 collaborators· click a node to visit their profile

Full network →

Compounds

PsilocybinLSDMDMADMTMescalineIbogaine

Topics

Neuroimaging & Brain MeasuresHealthy VolunteersDepressive DisordersAnxiety DisordersSubstance Use Disorders (SUD)Personality & Trait FactorsMajor Depressive Disorder (MDD)Medicinal Chemistry & Drug DevelopmentPalliative & End-of-Life DistressMicrodosingSchizophreniaPTSDSet & SettingSafety & Risk ManagementHeadache Disorders (Cluster & Migraine)Chronic PainAlcohol Use Disorder (AUD)Immunology & InflammationTreatment-Resistant Depression (TRD)

Top Collaborators

Affiliations

Institutions, companies, and organisations Gitte Knudsen is associated with.

University of Copenhagen

academic

The Neurobiology Research Unit (NRU) at Copenhagen University Hospital has been carrying out clinical and preclinical research with psychedelics since 2017. The team at the NRU utilizes various neuroimaging techniques to better understand how psychedelics exert their effects on the brain. They have published numerous peer-reviewed articles on psychedelics and facilitated numerous medium-dose psilocybin sessions. The NRU is led by Professor Gitte Moos Knudsen.

View stakeholder →